Skip to main content
Log in

Effectiveness of mastectomy by response to induction chemotherapy for control in inflammatory breast carcinoma

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background: Controversy exists as to the treatment regimen necessary to best provide optimal local control for inflammatory breast carcinoma (IBC). This study was conducted to determine if mastectomy combined with radiotherapy offered any advantages over radiotherapy alone in patients with IBC who had been treated with doxorubicin-based combination chemotherapy.

Methods: A retrospective review of 178 women treated for IBC on doxorubicin-based multimodality therapy protocols between January 1974 and September 1993 was performed. Clinical and histologic response to treatment, time to local recurrence, survival, and ultimate control of local disease were analyzed. Kaplan-Meier analysis was used to examine survival and relapse times, and Fisher's exact test was used to test differences in treatment outcomes. Significance was determined at p≤0.05.

Results: Median follow-up was 89 months (range 22 to 223 months). Locoregional disease persisted in seven patients and recurred in 44 patients who had been rendered disease free at a median time of 10 months. The mortality rate after a local recurrence (LR) was 98%, and all patients but one with LR developed systemic metastases. Response to induction chemotherapy influenced the incidence of LR, and the amount of residual disease found on histologic examination of mastectomy specimens was highly prognostic for local failure. Patients who underwent mastectomy in addition to radiotherapy had a lower incidence of LR than did patients who received radiotherapy alone (16.3% vs. 35.7%, p=0.015).

Conclusions: The addition of mastectomy to combination chemotherapy plus radiotherapy improved local control in patients with IBC. The addition of mastectomy to chemotherapy plus radiotherapy improved distant disease-free and overall survival in patients with a clinical complete or partial response to induction chemotherapy. Patients who had no significant response to induction chemotherapy received no survival or local disease-control benefit from the addition of mastectomy to their treatment regimen. These patients should be considered for entry into clinical trials of new treatment regimens.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bell C.A System of Operative Surgery. Vol 2. Hartford, CT: Hale & Hosmer, 1814.

    Google Scholar 

  2. Lee BJ, Tannenbaum NE. Inflammatory carcinoma of the breast: a report of twenty-eight (28) cases from the breast clinic of Memorial Hospital.Surg Gynecol Obstet 1924;39:580–95.

    Google Scholar 

  3. Taylor GW, Meltzer A. Inflammatory carcinoma of the breast.Am J Cancer 1938;33:33–49.

    Google Scholar 

  4. Haagensen CD.Diseases of the Breast. 2nd ed. Philadelphia: WB Saunders, 1971.

    Google Scholar 

  5. Treves N. The inoperability of inflammatory carcinoma of the breast.Surg Gynecol Obstet 1959;109:240–2.

    CAS  PubMed  Google Scholar 

  6. Byrd B Jr, Stevenson S Jr. Management of inflammatory breast cancer.South Med J 1960;53:945–8.

    PubMed  Google Scholar 

  7. Donegan WL.Staging and end results. In: Spratt JS Jr, Donegan WL, eds.Cancer of the Breast. Philadelphia: WB Saunders, 1967:117–61.

    Google Scholar 

  8. Robbins GF, Shah J, Rosen P, et al. Inflammatory carcinoma of the breast.Surg Clin North Am 1974;54:801–10.

    CAS  PubMed  Google Scholar 

  9. Bozzetti F, Saccozzi R, DeLena M, Salvadori B. Inflammatory cancer of the breast: analysis of 114 cases.J Surg Oncol 1981;18:355–61.

    CAS  PubMed  Google Scholar 

  10. Droulias CA, Sewell CW, McSweeney MB, Powell RW. Inflammatory carcinoma of the breast: a correlation of clinical, radiologic, and pathologic findings.Ann Surg 1976;184:217–22.

    CAS  PubMed  Google Scholar 

  11. Meyer AC, Dockerty MB, Harrington SW. Inflammatory carcinoma of the breast.Surg Gynecol Obstet 1948;87:417–24.

    Google Scholar 

  12. Chris SM. Inflammatory carcinoma of the breast: a result of 20 cases and a review of the literature.Br J Surg 1950;38:163–74.

    CAS  PubMed  Google Scholar 

  13. Rogers CS, Fitts WT. Inflammatory carcinoma of the breast: a critique of therapy.Surgery 1956;39:367–70.

    CAS  PubMed  Google Scholar 

  14. Dao TL, McCarthy JD. Treatment of inflammatory carcinoma of the breast.Surg Gynecol Obstet 1957;105:289–94.

    CAS  PubMed  Google Scholar 

  15. Richards G, Lewison E. Inflammatory carcinoma of the breast.Surg Gynecol Obstet 1961;113:729–32.

    PubMed  Google Scholar 

  16. Barber K, Dockerty M, Clagett O. Inflammatory carcinoma of the breast.Surg Gynecol Obstet 1961;112:406–10.

    PubMed  Google Scholar 

  17. Barker JL, Montague ED, Peters LJ. Clinical experience with irradiation of inflammatory carcinoma of the breast with and without elective chemotherapy.Cancer 1981;45:625–9.

    Google Scholar 

  18. Arriagada R, Mouriesse H, Spielmann M, et al. Alternating radiotherapy and chemotherapy in non-metastatic inflammatory breast cancer.Int J Radiat Oncol Biol Phys 1990;19:1207–10.

    CAS  PubMed  Google Scholar 

  19. Rouesse J, Friedman S, Sarrazin D, et al. Primary chemotherapy in the treatment of inflammatory breast carcinoma: a study of 230 cases from the Institut Gustave-Roussy.J Clin Oncol 1986;4:1765–71.

    CAS  PubMed  Google Scholar 

  20. Sherry MM, Johnson DH, Page DL, et al. Inflammatory carcinoma of the breast. Clinical review and summary of the Vanderbilt experience with multi-modality therapy.Am J Med 1985;79:355–64.

    Article  CAS  PubMed  Google Scholar 

  21. Buzdar AU, Montague ED, Barker JL, et al. Management of inflammatory carcinoma of breast with combined modality approach—an update.Cancer 1981;47:2537–42.

    CAS  PubMed  Google Scholar 

  22. Koh EH, Buzdar AU, Ames FC, et al. Inflammatory carcinoma of the breast: results of a combined-modality approach—M.D. Anderson Cancer Center experience.Cancer Chemother Pharmacol 1990;27:94–100.

    Article  CAS  PubMed  Google Scholar 

  23. Fields JN, Perez CA, Kuske RR, et al. Inflammatory carcinoma of the breast: treatment results on 107 patients.Int J Radiat Oncol Biol Phys 1989;17:249–55.

    CAS  PubMed  Google Scholar 

  24. Knight CD, Martin JK, Welch JS, et al. Surgical considerations after chemotherapy and radiation therapy for inflammatory breast cancer.Surgery 1986;99:385–91.

    PubMed  Google Scholar 

  25. Hagelberg RS, Jolly PC, Anderson RP. Role of surgery in the treatment of inflammatory breast carcinoma.Am J Surg 1984;148:125–31.

    Article  CAS  PubMed  Google Scholar 

  26. Moore MP, Ihde JK, Crowe JP Jr, et al. Inflammatory breast cancer.Arch Surg 1991;126:3304–6.

    Google Scholar 

  27. Schafer P, Alberto P, Forni M, et al. Surgery as part of a combined modality approach for inflammatory breast carcinoma.Cancer 1987;59:1063–7.

    CAS  PubMed  Google Scholar 

  28. Brun B, Otmezguine Y, Feuilhade F, et al. Treatment of inflammatory breast cancer with combination chemotherapy and mastectomy versus breast conservation.Cancer 1988;61:1096–103.

    CAS  PubMed  Google Scholar 

  29. Levine P, Steinhorn S, Ries L et al. Inflammatory breast cancer. The experience of the Surveillance Epidemiology and End Results (SEER) Program.J Natl Cancer Inst 1985;74:291–7.

    CAS  PubMed  Google Scholar 

  30. Singletary SE, Ames FC, Buzdar AU. Management of inflammatory breast cancer.World J Surg 1994;18:87–92.

    Article  CAS  PubMed  Google Scholar 

  31. Krutchik AN, Buzdar AU, Blumenschein GR, et al. Combined chemo-immunotherapy and radiation therapy of inflammatory breast carcinoma.J Surg Oncol 1979;11:325–32.

    CAS  PubMed  Google Scholar 

  32. Wiseman C, Jessup JM, Smith TL, et al. Inflammatory breast cancer treated with surgery, chemotherapy and allogeneic tumor cell/BCG immunotherapy.Cancer 1982;49:1266–71.

    CAS  PubMed  Google Scholar 

  33. Thoms WW, McNeese MD, Fletcher GH, et al. Multimodal treatment for inflammatory breast cancer.Int J Radiat Oncol Biol Phys 1989;17:739–45.

    PubMed  Google Scholar 

  34. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations.J Am Stat Assoc 1957;53:457–81.

    Google Scholar 

  35. Mantel N. Evaluation of survival data and two new rank order statistics rising in its consideration.Cancer Chemother Rep 1966;50:163–70.

    CAS  PubMed  Google Scholar 

  36. Camp E. Inflammatory carcinoma of the breast: the case for conservatism.Am J Surg 1976;131:583–6.

    Article  PubMed  Google Scholar 

  37. Sataloff DM, Mason BA, Prestipino AJ, Seinige UL, Lieber CP, Baloch Z. Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome.J Am Coll Surg 1995;180:297–304.

    CAS  PubMed  Google Scholar 

  38. Singletary SE, McNeese MD, Hortobagyi GN. Feasibility of breast conservation surgery after induction chemotherapy for locally advanced breast carcinoma.Cancer 1992;69:2849–52.

    CAS  PubMed  Google Scholar 

  39. Antman K, Bearman SI, Davidson N, et al. Dose intensive therapy in breast cancer: current status. In: Gale RP, Chanplin RE, eds.New Strategies in Bone Marrow Transplantation. New York: Alan R Liss, 1990:423–6.

    Google Scholar 

  40. Holmes FA, Walters RS, Theriault RL, et al. Phase II trial of taxol: an active drug in metastatic breast cancer.J Natl Cancer Inst 1991;83:1797–805.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fleming, R.Y.D., Asmar, L., Buzdar, A.U. et al. Effectiveness of mastectomy by response to induction chemotherapy for control in inflammatory breast carcinoma. Annals of Surgical Oncology 4, 452–461 (1997). https://doi.org/10.1007/BF02303668

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02303668

Key Words

Navigation